{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T11:00:36Z","timestamp":1778583636731,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["redjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.ijrobp.2017.06.008","type":"journal-article","created":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T04:31:43Z","timestamp":1498019503000},"page":"719-728","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Multisource Rotating Shield Brachytherapy Apparatus for Prostate Cancer"],"prefix":"10.1016","volume":"99","author":[{"given":"Hossein","family":"Dadkhah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolyn M.","family":"Hopfensperger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan T.","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2017.06.008_bib1","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/01.ju.0000113299.34404.22","article-title":"High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds","volume":"171","author":"Grills","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ijrobp.2010.02.013","article-title":"Monotherapeutic high-dose-rate brachytherapy for prostate cancer: Five-year results of an extreme hypofractionation regimen with 54 Gy in nine fractions","volume":"80","author":"Yoshioka","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib3","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.ijrobp.2010.09.006","article-title":"High-dose-rate brachytherapy as a monotherapy for favorable-risk prostate cancer: A phase II trial","volume":"82","author":"Barkati","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib4","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.ijrobp.2011.05.001","article-title":"High-dose-rate brachytherapy as monotherapy delivered in two fractions within one day for favorable\/intermediate-risk prostate cancer: Preliminary toxicity data","volume":"83","author":"Ghilezan","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib5","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.ijrobp.2011.04.031","article-title":"High-dose-rate brachytherapy alone for localized prostate cancer in patients at moderate or high risk of biochemical recurrence","volume":"82","author":"Hoskin","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib6","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.brachy.2014.03.002","article-title":"High-dose-rate brachytherapy as monotherapy for prostate cancer","volume":"13","author":"Demanes","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib7","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/cncr.22810","article-title":"Long-term outcomes after treatment with brachytherapy and supplemental conformal radiation for prostate cancer patients having intermediate and high-risk features","volume":"110","author":"Dattoli","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib8","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.ijrobp.2010.05.044","article-title":"Development of late toxicity and International Prostate Symptom Score resolution after external-beam radiotherapy combined with pulsed dose rate brachytherapy for prostate cancer","volume":"81","author":"Pieters","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.radonc.2012.07.003","article-title":"Long term results of a prospective dose escalation phase-II trial: Interstitial pulsed-dose-rate brachytherapy as boost for intermediate- and high-risk prostate cancer","volume":"104","author":"Lettmaier","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib10","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0360-3016(02)02733-5","article-title":"Dose escalation using conformal high-dose-rate brachytherapy improves outcome in unfavorable prostate cancer","volume":"53","author":"Martinez","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib11","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.ijrobp.2004.08.014","article-title":"High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California Endocurietherapy's 10-year results","volume":"61","author":"Demanes","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib12","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.eururo.2004.11.014","article-title":"High dose rate (HDR) brachytherapy with conformal radiation therapy for localized prostate cancer","volume":"47","author":"Deger","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib13","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ijrobp.2004.11.041","volume":"63","author":"Akimoto","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib14","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.radonc.2007.04.011","article-title":"High dose rate brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer: Initial results of a randomised phase three trial","volume":"84","author":"Hoskin","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.radonc.2012.01.007","article-title":"Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer","volume":"103","author":"Hoskin","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.radonc.2013.05.002","article-title":"GEC\/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: An update","volume":"107","author":"Hoskin","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib17","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1200\/JCO.2008.18.6486","article-title":"Individualizing quality-of-life outcomes reporting: How localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function","volume":"27","author":"Chen","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib18","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1056\/NEJMoa074311","article-title":"Quality of life and satisfaction with outcome among prostate-cancer survivors","volume":"358","author":"Sanda","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib19","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0022-5347(05)00681-6","article-title":"Risk factors for the development of prostate brachytherapy related urethral strictures","volume":"175","author":"Merrick","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib20","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ijrobp.2010.10.009","article-title":"Comparison of acute and late toxicities for three modern high-dose radiation treatment techniques for localized prostate cancer","volume":"82","author":"Mohammed","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib21","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.brachy.2012.03.004","article-title":"Urethral strictures following high-dose-rate brachytherapy for prostate cancer: Analysis of risk factors","volume":"12","author":"Hindson","year":"2013","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib22","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.radonc.2008.11.013","article-title":"Urethral stricture following high dose rate brachytherapy for prostate cancer","volume":"91","author":"Sullivan","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib23","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.juro.2007.03.126","article-title":"Incidence of urethral stricture after primary treatment for prostate cancer: Data From CaPSURE","volume":"178","author":"Elliott","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.brachy.2009.04.007","article-title":"High-dose-rate brachytherapy in combination with conformal external beam radiotherapy in the treatment of prostate cancer","volume":"9","author":"Zwahlen","year":"2010","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib25","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.juro.2006.06.002","article-title":"Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer","volume":"176","author":"Zelefsky","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib26","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.radonc.2009.03.013","article-title":"Urinary toxicity after high dose intensity modulated radiotherapy as primary therapy for prostate cancer","volume":"92","author":"Fonteyne","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijrobp.2008.11.006","volume":"75","author":"Ishiyama","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib28","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ijrobp.2009.08.048","article-title":"Phase II trial of combined high-dose-rate brachytherapy and external beam radiotherapy for adenocarcinoma of the prostate: Preliminary results of RTOG 0321","volume":"78","author":"Hsu","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib29","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.ijrobp.2010.04.046","article-title":"Health-related quality of life after single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for prostate cancer","volume":"80","author":"Morton","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib30","doi-asserted-by":"crossref","first-page":"121703","DOI":"10.1118\/1.4828778","article-title":"Dynamic rotating-shield brachytherapy","volume":"40","author":"Liu","year":"2013","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib31","doi-asserted-by":"crossref","first-page":"051703","DOI":"10.1118\/1.4870441","article-title":"Interstitial rotating shield brachytherapy for prostate cancer","volume":"41","author":"Adams","year":"2014","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib32","doi-asserted-by":"crossref","first-page":"6579","DOI":"10.1118\/1.4933244","article-title":"Multihelix rotating shield brachytherapy for cervical cancer","volume":"42","author":"Dadkhah","year":"2015","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib33","doi-asserted-by":"crossref","first-page":"5992","DOI":"10.1118\/1.4930807","article-title":"Paddle-based rotating-shield brachytherapy","volume":"42","author":"Liu","year":"2015","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib34","doi-asserted-by":"crossref","first-page":"051720","DOI":"10.1118\/1.4802750","article-title":"Rapid emission angle selection for rotating-shield brachytherapy","volume":"40","author":"Liu","year":"2013","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib35","doi-asserted-by":"crossref","first-page":"111709","DOI":"10.1118\/1.4897617","article-title":"Asymmetric dose-volume optimization with smoothness control for rotating-shield brachytherapy","volume":"41","author":"Liu","year":"2014","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib36","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1088\/0031-9155\/58\/4\/957","article-title":"Gadolinium-153 as a brachytherapy isotope","volume":"58","author":"Enger","year":"2013","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib37","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF03178889","article-title":"Potential dose-conformity advantages with multi-source intensity-modulated brachytherapy (IMBT)","volume":"29","author":"Ebert","year":"2006","journal-title":"Australas Phys Eng Sci Med"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib38","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ijrobp.2012.03.035","article-title":"High-dose-rate prostate brachytherapy consistently results in high quality dosimetry","volume":"85","author":"White","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib39","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.brachy.2014.05.006","article-title":"Ultrasound-planned high-dose-rate prostate brachytherapy: Dose painting to the dominant intraprostatic lesion","volume":"13","author":"Crook","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib40","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.radonc.2016.04.006","article-title":"High-dose-rate interstitial brachytherapy as monotherapy in one fraction for the treatment of favorable stage prostate cancer: Toxicity and long-term biochemical results","volume":"119","author":"Prada","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib41","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijrobp.2016.08.011","article-title":"Favorable preliminary outcomes for men with low- and intermediate-risk prostate cancer treated with 19-Gy single-fraction high-dose-rate brachytherapy","volume":"97","author":"Krauss","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib42","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.radonc.2016.10.019","article-title":"Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Early toxicity and quality-of life results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy","volume":"122","author":"Morton","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2017.06.008_bib43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.brachy.2013.08.004","article-title":"Validation study of ultrasound-based high-dose-rate prostate brachytherapy planning compared with CT-based planning","volume":"13","author":"Batchelar","year":"2014","journal-title":"Brachytherapy"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030161731057X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030161731057X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T11:51:40Z","timestamp":1535716300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036030161731057X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S036030161731057X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2017.06.008","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multisource Rotating Shield Brachytherapy Apparatus for Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2017.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}